Methotrexate Nodulosis How good (or not) are rheumatologists and what to do about MTX nodulosis? https://t.co/Ot9UfpH68N https://t.co/JQ2AtuE7NV

11-yr French study of #RA Pregnancies: more adverse Preg outcomes in RA, esp w/ active Dz. 11.8K RA vs 10.4 million non-RA Pregs. 75% live births in RA. RA had more preterm(aOR 1.84), low birth wt (1.65), C-Sect (1.46), hospz (1.30), & prematurity (2.02)https://t.co/v9CmiPkIBG https://t.co/S0siiuG0oZ

Mexico survey of 250 RA pts -- 92% used complementary (CAM) therapies - mostly: herbals (65%), homeopathy (64%), cannabis derivatives (51%). Poor DMARD adherence assoc w/ age (p=0.019), comorbidities (p=0.047), CAM use (p = 0.042) (OR 2.84) https://t.co/EGxyIVCMnk https://t.co/jjF5cH53we

FDA Safety Warning: denosumab now has a Boxed Warning for risk of severe hypocalcemia in CKD pts taking Prolia (usually seen 2-10 wks post injx). Pts may or may not be symptomatic. CKD pts should have Ca and Creatinine monitored. https://t.co/tGiG35cOnv https://t.co/ITOZneGKtb

Rheumatologists and the Early Diagnosis of Spondyloarthritis SPACE study of adults referred to rheumatology with less than 2 years of chronic back pain (CBP), shows that only one-third can be reliably diagnosed with axial spondyloarthritis (axSpA). https://t.co/EwrrunyZs7. https://t.co/T0OqlsuU2P

Rituximab Efficacy in MAINRITSAN Long-Term Studies https://t.co/z16uMDihV4 https://t.co/BaWFcwDbYL

Sodium Channels, Carbemazepine and Osteoarthritis Progression A study published in Nature suggests that therapies affecting sodium channels could be employed to treat osteoarthritis. https://t.co/hmzKsgb3gA https://t.co/WVgk8nD4ne

You can still attend RheumNow Live! Below is a preview of one of our "STEP" talks - by Mike Putman, MD, who brings his vast knowledge to the forefront, shedding light on Myths & Mistakes on ANCA-Associated Vasculitis. https://t.co/LzcVytLDij Register: https://t.co/NWXKNhQzc5 https://t.co/ogAfTtH5Nk

New download available! Seasonal Flu Vaccination in RA Patients https://t.co/tNwgUVoG7Z https://t.co/P1UqPU57WU

IL-17 pathway as a target in giant cell arteritis - full read review of pathogenic role of IL-17 and Th17 cells, in #GCA; backed up by the phase II proof-of-principle TiTAIN study showing potential efficacy of secukinumab in GCA pts https://t.co/MThzw2joGO https://t.co/PmrJjf9C3a

2023 EULAR Non-pharmacological Management of Hip and Knee Osteoarthritis: 2023 update EULAR has published the 2023 updated recommendations for the optimal non-pharmacological management of hip and knee osteoarthritis (OA). https://t.co/OjmdAnRWtl https://t.co/gfWYopEgtt